Patient eligibility and trial design for the salvage therapy of advanced urothelial carcinoma

Clin Genitourin Cancer. 2014 Dec;12(6):395-8. doi: 10.1016/j.clgc.2014.03.016. Epub 2014 Jun 10.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Transitional Cell / drug therapy*
  • Clinical Trials, Phase II as Topic*
  • Humans
  • Patient Selection*
  • Research Design
  • Salvage Therapy / methods*
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents